Diagnostic Value of a Novel Junctional Cardiometabolic Index for Identifying Reduced Left Ventricular Ejection Fraction in Chinese Patients with Heart Failure: A Retrospective Observational Study

Imagine your heart as the main engine of a bustling city, pumping life-giving blood through a complex network of roads. Sometimes, that engine starts to sputter or lose its power, a condition doctors call heart failure. For decades, the gold standard for checking how well this engine is working has been a special camera scan called an echocardiogram, which takes a picture of the heart's squeezing strength. But pictures can be tricky; they depend on who is holding the camera and how clear the view is. So, scientists have long searched for a simpler "smoke detector"—a chemical signal in the blood that tells us if the engine is struggling before we even need to take a picture. One such signal, called NT-proBNP, has been the go-to detective, but it sometimes gets confused by other things in the body, like age or kidney issues, leading to false alarms or missed clues.

This brings us to a new idea: what if we didn't rely on just one detective, but instead formed a "super-team" of three different signals working together? Heart failure isn't just a heart problem; it's a city-wide crisis that messes up the liver, the blood's clotting system, and the body's nutrition. By combining clues from these different systems, researchers hope to build a more accurate map of what's really happening inside. This is the story of a new study that tested a fresh, composite tool to see if it could spot a weak heart better than the old, single detective.

---

The New "Super-Score" for a Failing Heart

In this study, a team of researchers from the Fifth Affiliated Hospital of Xinjiang Medical University decided to test a brand-new tool they invented, which they call the Novel Junctional Cardiometabolic Index (NJCI). Think of the NJCI as a "super-score" that combines three different pieces of information from a standard blood test into one magic number.

Here is how the score is built:

1. The Liver Clue (Total Bilirubin): When the heart struggles, blood can back up into the liver, like traffic jamming a highway. This causes a chemical called bilirubin to rise.
2. The Clotting Clue (D-dimer): A struggling heart can make the blood feel "sticky" or prone to clotting, which releases a marker called D-dimer.
3. The Nutrition Clue (Albumin): When the body is under stress and inflamed, it often loses its main protein, albumin, which is like the city's construction crew running out of supplies.

The researchers took the natural log (a mathematical way to smooth out big numbers) of the liver clue and the clotting clue, multiplied them together, and then divided by the nutrition clue. The result is the NJCI. The higher the score, the more chaotic the city's systems are, suggesting the heart engine is in trouble.

The Big Showdown: NJCI vs. The Old Detective

To see if this new "super-score" was any good, the researchers looked back at the medical records of 338 patients who were already diagnosed with heart failure. They split these patients into two groups based on a heart scan:

• Group A: Patients with a "reduced" engine power (Left Ventricular Ejection Fraction, or LVEF, less than 45%).
• Group B: Patients with a "preserved" engine power (LVEF 45% or higher).

The team then compared how well the new NJCI score could tell these two groups apart versus the old standard, NT-proBNP.

What They Found

The results were quite striking. The patients with the weak engines (reduced LVEF) had significantly higher NJCI scores than those with stronger engines. When the researchers ran a statistical test called a "ROC curve" (which measures how good a test is at finding the truth), the NJCI scored an AUC of 0.903.

To put that in perspective, imagine a test that is perfect gets a score of 1.0, and a test that is just guessing gets a score of 0.5. The NJCI's score of 0.903 is very close to perfect. In comparison, the old detective, NT-proBNP, scored an AUC of 0.773. While the old detective was decent, the new NJCI "super-score" was clearly better at spotting the patients with the reduced engine power.

The researchers also calculated a "cut-off" point for the NJCI. If a patient's score was 0.383 or higher, the test was 98.7% likely to correctly identify them as having a weak heart. This is an incredibly high "sensitivity," meaning it rarely misses a case. However, it did have a lower "specificity" (41.0%), meaning it sometimes flagged people who were actually okay as being at risk. But in a life-or-death situation like heart failure, catching almost everyone who is sick is often more important than avoiding false alarms.

Why This Matters

The study used a statistical method called "binary logistic regression" to prove that the NJCI wasn't just riding on the coattails of the other tests. Even after accounting for the NT-proBNP levels and other factors, the NJCI remained a strong, independent predictor of a weak heart. The model explained 57.2% of the variation in the data, showing it captures a lot of the story that other tests miss.

The authors suggest that the NJCI works so well because heart failure is a messy, multi-system problem. A single test like NT-proBNP only looks at the heart's pressure. But the NJCI looks at the whole city: the liver congestion, the sticky blood, and the nutritional stress. By combining these three different "languages" of the body, the NJCI creates a more complete picture of the chaos caused by a failing heart.

A Note of Caution

While the results are exciting, the researchers are careful not to declare victory just yet. They point out that this study was done at a single hospital with a specific group of Chinese patients. This means we don't know yet if the NJCI works just as well for people of different ethnicities or in different parts of the world. Also, because this was a "retrospective" study (looking back at old records), it can't prove that the NJCI causes the diagnosis or predict future events; it only shows a strong link in the past data.

The Bottom Line

This study suggests that the Novel Junctional Cardiometabolic Index (NJCI) is a powerful new tool that might be even better than the current standard for identifying patients with a weak heart pump. By mixing clues from the liver, blood clotting, and nutrition into one score, it offers a more holistic view of the patient's condition. While it needs more testing in larger, diverse groups to confirm its global usefulness, it represents a promising step toward simpler, more accurate ways to keep our heart engines running smoothly.